Abstract | OBJECTIVE:
Leuprolide acetate (LA) has improved the efficiency of human menopausal gonadotropins (hMG) in in vitro fertilization cycles. We hypothesized that the combination of LA/hMG/intrauterine insemination (IUI) would be more efficacious than hMG/IUI cycles. DESIGN: During an 18-month period, all patients completing either a hMG/IUI cycle (group I) or a LA/hMG/IUI cycle (group II) had the characteristics and outcomes of their stimulation cycles assessed. The groups were not prospectively randomized. SETTING: Referral center at a tertiary care hospital. PATIENTS: One hundred twenty three patients in group I completed 219 cycles, and 64 patients in group II completed 102 cycles. Twenty-eight of the patients who failed to conceive with hMG/IUI were advanced to group II. MAIN OUTCOME MEASURES: Pregnancy/IUI is compared between the two groups. RESULTS: Group II demonstrated significantly greater clinical pregnancy/IUI than group I (26.5% and 16.0%, respectively, P less than 0.05), as well as a higher live birth/IUI (21.6% and 12.8%, respectively, P less than 0.05). No difference was present in the rate of fetal wastage or multiple births. CONCLUSIONS: In our patients with recalcitrant infertility, the addition of a gonadotropin-releasing hormone agonist to hMG/IUI improved the pregnancy rate, without increasing the rate of multiple births or fetal wastage.
|
Authors | C L Gagliardi, A M Emmi, G Weiss, C L Schmidt |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 55
Issue 5
Pg. 939-44
(May 1991)
ISSN: 0015-0282 [Print] United States |
PMID | 1902421
(Publication Type: Journal Article)
|
Chemical References |
- Gonadotropin-Releasing Hormone
- Menotropins
- Leuprolide
|
Topics |
- Female
- Gonadotropin-Releasing Hormone
(administration & dosage, analogs & derivatives, therapeutic use)
- Humans
- Infertility
(etiology, therapy)
- Insemination, Artificial
(methods)
- Leuprolide
- Male
- Menotropins
(administration & dosage, therapeutic use)
- Ovary
(physiology)
- Pregnancy
- Pregnancy, Multiple
|